Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Tarsus Pharmaceuticals is a US-based biopharmaceutical company dedicated to developing innovative therapeutic solutions for eye care. The company focuses on addressing conditions like Demodex blepharitis by utilizing advanced, science-based approaches to improve patient outcomes in ophthalmology.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Tarsus Pharmaceuticals is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Tarsus Pharmaceuticals last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.43 USD.
Across its last 3 earnings reports, Tarsus Pharmaceuticals stock moved by ±5.2% on average the following day. The largest reaction was +7.8% on 02/23/2026; 2 of 3 reactions were positive.
Tarsus Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.